3455 — Healthcare & Medical Investment Cashflow Statement
0.000.00%
- ¥41bn
- ¥82bn
- ¥5bn
- 30
- 49
- 51
- 38
Annual cashflow statement for Healthcare & Medical Investment, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,863 | 1,833 | 2,015 | 2,348 | 2,106 |
Depreciation | |||||
Non-Cash Items | 319 | 316 | 326 | 378 | 448 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 7.16 | -122 | -193 | 919 | -219 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,086 | 2,968 | 3,179 | 4,769 | 3,491 |
Capital Expenditures | -1,857 | -1,044 | -12,518 | -2,409 | -2,935 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 71.5 | 60 | 137 | 15.2 | -52.6 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,785 | -984 | -12,381 | -2,394 | -2,988 |
Financing Cash Flow Items | -94.4 | -62.2 | -244 | -148 | -207 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,572 | -2,074 | 9,040 | -2,135 | -48.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -270 | -89.3 | -162 | 240 | 455 |